Novartis 7 and 12 year grows from €1bn to €1.2bn in improved market

© 2025 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 4 Bouverie Street, London, EC4Y 8AX. Part of the Delinian group. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions

Novartis 7 and 12 year grows from €1bn to €1.2bn in improved market

Novartis 230x150

Novartis returned to the euro bond market on Friday October 31 after five years to issue seven and 12 year notes. A solid market allowed the total size to grow from an expected €1bn to €1.2bn.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login
Gift this article